WIGGINS MARK C

Track

Insider profile

Performance

Overall performance
1.0
Performance over holding periods
1.0
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
WIGGINS MARK C's trades of TRACON Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
341.11
Quantity 21,966 -32.9%
Value US$3,194,216
US Zogenix Inc (ZGNX)
Transaction date
Purchase
Price
20.48
Quantity 2,500 +inf%
Value US$51,196
US Biogen Inc (BIIB)
Transaction date
Planned sale
Price
62.49
Quantity 12,500 -13.7%
Value US$781,125
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-30 2020-12-29
B Purchase
21,966 -32.9%
341.11
US$3,194,216 		21,966 -32.9% 341.11 US$3,194,216
2020-12-30 2020-12-29
PP Planned purchase
16,569 +39.8%
437.66
US$2,512,819 		16,569 +39.8% 437.66 US$2,512,819
2020-09-14 2020-09-10
PP Planned purchase
94,066 +41.8%
255.50
US$4,688,840 		94,066 +41.8% 255.50 US$4,688,840
2020-03-24 2020-03-23
US Zogenix Inc (ZGNX)
B Purchase
2,500 +inf%
20.48
US$51,196 		2,500 +inf% 20.48 US$51,196
2020-01-24 2020-01-23
B Purchase
5,000 +inf%
4.02
US$20,102 		5,000 +inf% 4.02 US$20,102
2004-10-06 2004-10-04
US Biogen Inc (BIIB)
PlS Planned sale
12,500 -13.7%
62.49
US$781,125 		12,500 -13.7% 62.49 US$781,125